艾美疫苗 06660 Prospectus Information

IPO Timeline

Broker Results (T-2)

2022-10-03

Some brokers release in afternoon

Grey Market (T-1)

2022-10-05

Afternoon

HKEX Allotment (T-1)

2022-10-05

Evening

Registrar Allotment (T-1)

2022-10-05

Evening

Listing Day (T)

2022-10-06

First day of trading

Company Overview

Stock Name	艾美疫苗
Stock Code	06660
Company Full Name	艾美疫苗
Industry	醫療保健
Principal Activities	主要在中國從事人用疫苗產品的研發、生產及商業化。
Listing Date	2022-10-06
Listing Rules Era	Old Rules
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	中國北京市朝陽區建國路91號金地中心A座25層
Business Address (Hong Kong)	To be extracted
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	https://www.aimbio.com/
Share Registrar	卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact	(852)2980 1333
A-Share/US Dual Listing	No data

Offering Information

Offering Mechanism	To be extracted
Offer Price	HK$ 16.16 / shares
Offer Price Range	To be extracted
Lot Size	To be extracted
Entry Threshold	To be extracted
Par Value	To be extracted
Offer Period	To be extracted
Global Offering Shares	To be extracted
HK Public Offer Shares (Initial)	To be extracted
Public Offer Lots (Initial)	To be extracted
International Placing Shares (Initial)	To be extracted
Offer Ratio	To be extracted
Total Shares Post-IPO	To be extracted
Greenshoe (Over-allotment Option)	To be confirmed
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	0%
Clawback Tiers	To be extracted
Reallocation Option	To be confirmed
Total Global Offering Size	HK$ 15,701,056

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1 lots	200	HK$ 3,232
2 lots	400	HK$ 6,464
3 lots	600	HK$ 9,696
4 lots	800	HK$ 12,928
5 lots	1,000	HK$ 16,160
6 lots	1,200	HK$ 19,392
7 lots	1,400	HK$ 22,624
8 lots	1,600	HK$ 25,856
9 lots	1,800	HK$ 29,088
10 lots	2,000	HK$ 32,320
15 lots	3,000	HK$ 48,480
20 lots	4,000	HK$ 64,640
25 lots	5,000	HK$ 80,800
30 lots	6,000	HK$ 96,960
35 lots	7,000	HK$ 113,120
40 lots	8,000	HK$ 129,280
45 lots	9,000	HK$ 145,440
50 lots	10,000	HK$ 161,600
100 lots	20,000	HK$ 323,200
150 lots	30,000	HK$ 484,800
200 lots	40,000	HK$ 646,400
250 lots	50,000	HK$ 808,000
300 lots	60,000	HK$ 969,600
400 lots	80,000	HK$ 1,292,800
500 lots	100,000	HK$ 1,616,000
600 lots	120,000	HK$ 1,939,200
900 lots	180,000	HK$ 2,908,800

Pool B

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
2,429 lots	485,800	HK$ 7,850,528

Valuation & Financials

Market Cap (at Offer Price)	To be extracted
Pre-IPO Valuation (Last Round)	To be extracted
P/E Ratio	To be extracted
Profit/Loss Status	To be extracted
Period-End Cash Balance	To be extracted
Listing Expenses	To be extracted
Listing Expenses / Funds Raised	To be extracted
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	HK$ 16.66
First Day Open	HK$ 15.0
First Day Change	-83.79%
First Day Volume	1170400.0
First Day Turnover	18432000.0

Use of Proceeds

Use of Proceeds	1、約60%或42.00百萬港元將分配用于推進我們在研疫苗的研發及持續豐富我們的疫苗管線； 2、約35%或24.50百萬港元將用于為建設新生產設施的資本開支提供資金； 3、約5%或3.51百萬港元將投入我們的銷售及營銷活動以鞏固及擴大市場領導地位。

Underwriting Syndicate

Joint Sponsors (4)

高盛（亚洲）有限责任公司 CE ACC536 中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112 麦格理资本股份有限公司 CE AAC534

Overall Coordinators (4)

高盛（亚洲）有限责任公司 CE ACC536 中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112 麦格理资本股份有限公司 CE AAC534

Joint Bookrunners (9)

高盛（亚洲）有限责任公司 CE ACC536 中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112 麦格理资本股份有限公司 CE AAC534 中银国际亚洲有限公司 CE AET863 工银国际证券有限公司 CE ARO299 招银国际融资有限公司 CE AVM940 富途证券国际（香港）有限公司 CE AZT137 老虎证券（香港）环球有限公司 CE BMU940

Joint Lead Managers (10)

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

Chairman	周延
Company Secretary	劉靈

No director data available.

Major Shareholders

Major Shareholders & Holdings	周延(33.9%)

Subscription Tiers

IPO Timeline

艾美疫苗 06660Prospectus Information